Startup healthcare company Ariosa Diagnostics has inked a deal with laboratory heavyweight LabCorp to distribute and administer its blood-based prenatal test. The partnership, announced Monday, ...
Jan 25 (Reuters) - Gene testing company Illumina on Thursday won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented ...
SAN JOSE, Calif., June 11, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX:RHHBY). Ariosa Diagnostics, Inc., a global leader in non-invasive prenatal testing (NIPT) technology and maker of the Harmony ...
SAN JOSE, Calif., June 11, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX:RHHBY). Ariosa Diagnostics, Inc., a global leader in non-invasive prenatal testing (NIPT), today announced its proprietary ...
Lawyers for Illumina Inc. and Ariosa Diagnostics—rivals in the burgeoning market for non-invasive prenatal testing (NIPT)—both asked a San Francisco federal jury for damage awards of around $100 ...
The latest patent battle battle between Illumina Inc. and Ariosa Diagnostics Inc. over Ariosa's Harmony prenatal test ended quicker than the first. U.S. District Judge Susan Illston on Monday ruled ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Ariosa Diagnostics is already a favorite with pregnant women. But it's about to become a big name on Wall Street, too, with its initial public offering. Ariosa plans to offer $69 million in a proposed ...
On June 12, 2015, the United States Court of Appeals for the Federal Circuit issued a decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc. The decision dealt with whether a non-invasive method for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results